Press Releases Affluent Medical

Equities

AFME

FR0013333077

Market Closed - Euronext Paris Other stock markets 08:59:45 2024-05-16 am EDT			5-day change	1st Jan Change
1.685 ^EUR	-2.03%		-5.34%	-8.67%

Apr. 25	Affluent Medical SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 13	AFFLUENT MEDICAL : Invest Securities reiterates its opinion	CF

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Affluent Medical : 2023 financial results and update on clinical activities under development.	Apr. 25	EQ
Affluent Medical announces coverage initiation of its stock by Gilbert Dupont – Société Générale Group.	Apr. 04	EQ
Affluent Medical : announces coverage initiation of its stock by TP ICAP Midcap.	Mar. 28	PU
Affluent Medical announces coverage initiation of its stock by TP ICAP Midcap.	Mar. 28	EQ
Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence.	Mar. 12	EQ
Affluent Medical : Excellent valve performance at 1 year follow up and rising recognition of Epygon biomimetic mitral valve.	Feb. 29	EQ
Affluent Medical closes €3.5 million bridge via capital increase from key shareholders.	Jan. 29	EQ
Affluent Medical : Half-year liquidity contract statement for Affluent Medical.	Jan. 29	EQ
Affluent Medical : Pre-submission dossier for the 510(k) of medical device KaliosTM filed with FDA for review.	Jan. 15	EQ
Affluent Medical : Start of the European pilot study with the Artus medical device for the treatment of urinary incontinence.	Dec. 06	EQ
Affluent Medical announces coverage initiation of its stock by Portzamparc – Groupe BNP Paribas.	Nov. 27	EQ
Affluent Medical : H1 2023 results. Major advances in clinical programs. Extension of cash horizon to February 2024.	23-09-28	EQ
Affluent Medical SA: H1 2023 RESULTS - Major advances in clinical programs - Extension of cash horizon to February 2024	23-09-28	EQ
Affluent Medical announces positive clinical results and further insights to enhance its strategy on Structural Heart activities.	23-09-13	EQ
Affluent Medical announces positive clinical results and further insights to enhance its strategy on Structural Heart activities	23-09-13	EQ
Affluent Medical : Half-year liquidity contract statement.	23-07-25	EQ
Affluent Medical strengthens management team to advance its development.	23-07-17	EQ
Affluent Medical strengthens management team to advance its development	23-07-17	EQ
Affluent Medical : Increase in resources allocated to the liquidity contract with Kepler Cheuvreux.	23-07-10	EQ
Affluent Medical Presents Poster on First Successful Procedure with Epygon at the 2023 CSI Conference in Frankfurt	23-06-28	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Affluent Medical

Equities

AFME

FR0013333077

Press Releases

Filters